- Advertisement -

City of Hope Helps Found Biotechnology Hub for Los Angeles County’s Life Sciences Industry – Business Wire

DUARTE, Calif.--(BUSINESS WIRE)--City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, today announced that it is...

Swiss Biotech Day shows great biopharma ambitions – European Biotechnology News

The Swiss biopharmaceutical industry is on the verge of record growth: This was demonstrated at the live Swiss Biotech Day in Basel. ...

Bacteria “Croak” in the Presence of Toadlet Peptide

Antibacterial peptides are found across the animal kingdom, serving roles in nature by fighting microbial infections and diseases such as cancer. Now researchers at...

Study uncovers dangerous side effects of AZD7648 in gene editing

Genome editing with various CRISPR-Cas molecule complexes has progressed rapidly in recent years. Hundreds of labs around the world are now working to put...

Uncovering the Secrets of AAV for Improved Cell and Gene Therapies

REGISTER NOW Broadcast Date: October 5, 2021Time: 8:00 am PT, 11:00 am ET, 17:00 CET We are all keenly aware that viruses can negatively impact...

New insights into the genomic landscape of meningiomas identified FGFR3 in...

The identification of oncogenic mutations has provided further insights into the tumorigenesis of meningioma and the possibility of targeted therapy Credit: Malak Abedalthagafi, email: malthagafi@kfmc.med.sa

New Catalytic Reactive-Hydrogen Membranes Capture and Break Down PFAS

Researchers at Arizona State University (ASU) and collaborating institutions have developed catalytic reactive-hydrogen membranes that capture and chemically break down six per- and polyfluoroalkyl...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

New Catalytic Reactive-Hydrogen Membranes Capture and Break Down PFAS

Researchers at Arizona State University (ASU) and collaborating institutions have developed catalytic reactive-hydrogen membranes that capture and chemically break down six per- and polyfluoroalkyl...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...

more new items

New Catalytic Reactive-Hydrogen Membranes Capture and Break Down PFAS

Researchers at Arizona State University (ASU) and collaborating institutions have developed catalytic reactive-hydrogen membranes that capture and chemically break down six per- and polyfluoroalkyl...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...